AstraZeneca announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has received marketing authorisation for roxadustat...
Read moreRentschler Fill Solutions GmbH, a contract development and manufacturing organization (CDMO) and expert for aseptic filling and finishing of biopharmaceuticals,...
Read moreADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and...
Read more DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in...
Read moreBayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered...
Read moreLexaGene Holdings, Inc. , a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced ...
Read moreDynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced...
Read moreStoke Therapeutics, Inc , a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by...
Read moreEton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced that Aucta Pharmaceuticals' New...
Read moreAevi Genomic Medicine, Inc announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.